BG
CPHR

BlackRock Group’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

BlackRock Group’s Portfolio CPHR Stock Details CPHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,317
Closed -$140K – 3126
2015
Q2 		$140K Hold
16,317
– – ﹤0.01% 2671
2015
Q1 		$148K Buy
16,317
+6,452
+65% +$81K ﹤0.01% 2576
2014
Q4 		$140K Buy
+9,865
New +$143K ﹤0.01% 2597

Other funds holding CPHR

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

BlackRock Group's CPHR Position: Q3 2015 in Review

BlackRock Group sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q3 2015, closing a stake of 16,317 shares — an estimated $140K sold.

BlackRock Group first reported a position in CPHR in Q4 2014 and held it in 3 quarters. The position peaked at $148K in Q1 2015. 24 funds tracked by Wall St. Rank hold CPHR as of Q3 2015.

  • BlackRock Group reported no remaining Cipher Pharmaceuticals Inc. position as of Q3 2015 after selling out during the quarter.
  • BlackRock Group sold 16,317 Cipher Pharmaceuticals Inc. shares in Q3 2015, an estimated $140K.
  • BlackRock Group first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 3 quarters.
  • BlackRock Group's Cipher Pharmaceuticals Inc. position peaked at $148K in Q1 2015.
  • 24 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q3 2015.

Based on BlackRock Group's 13F filing for Q3 2015, filed 13 Nov 2015.